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Background: Diverse and circumstantial evidence suggests that schizophrenia is a 
neurodevelopmental disorder. Genes contributing to neurodevelopment may be po-
tential candidates for schizophrenia. The human SOX11 gene is a member of the de-
velopmentally essential SOX	(Sry-related	HMG	box)	transcription	factor	gene	family	
and	mapped	to	chromosome	2p,	a	potential	candidate	region	for	schizophrenia.
Methods: Our	 previous	 genome-wide	 association	 study	 (GWAS)	 implicated	 an	 in-
volvement of SOX11	 with	 schizophrenia	 in	 a	 Chinese	 Han	 population.	 To	 further	












can recruit divergent factors.
Conclusions: Our results suggest SOX11	as	a	susceptibility	gene	for	schizophrenia,	
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a steady prevalence of ~1% historically and worldwide.1	With	a	peak	
onset	at	18-25	years	old,	schizophrenia	inflicts	physical	and	mental	suf-
fering on the affected individuals and their families with high medical 
and social costs.2	Searching	for	specific	biomarkers	for	schizophrenia	
plays	an	 important	 role	 in	 identifying	 the	disease	state,	contributing	
on	 underlying	 progression,	 and	 predicting	 the	 treatment	 response.3 
In	the	last	centuries,	studies	for	schizophrenia	focused	on	the	natural	
course	of	 the	disease,	which	various	environmental	and	genetic	 risk	







schizophrenia	have	been	 identified,5 resulting in the conclusion that 
schizophrenia	is	a	polygenic	and	complex	disorder.
Despite	more	 than	a	century	of	 research,	 the	pathophysiologi-
cal	basis	of	schizophrenia	remains	undefined.	By	far,	a	vast	majority	
of evidence revealed that schizophrenia is a neurodevelopmental 
disorder which indicates schizophrenia onset in late adolescence or 
early	adulthood,	 risk	 factors	operating	mostly	prenatally	or	during	
early	childhood,	general	differences	in	intellect	and	behavior	many	
years	 before	 onset,	 structural	 brain	 changes	 at	 or	 before	 onset,	
cognitive	 impairments,	 and	 functional	 alternatives	 of	 several	 neu-
rodevelopmental	 genes	 (DISC1,	 NRG1,	 RELN,	 BDNF,	 and	 etc).6-11 
Neurodevelopment	 comprises	 multiple	 delicately	 tuned	 steps,	 in-
cluding	the	proliferation,	differentiation,	migration,	and	integration	
of a variety of neural cell types.12	The	risks	and	insults	to	neurode-
velopment occurring in the prenatal and postnatal stages have been 
related to the formation activation of aberrant neural circuits and 




human SOX11 gene. SOX11 is a member of the developmentally es-
sential SOX	(Sry-related	HMG	box)	transcription	factor	gene	family	




lead	to	all	kinds	of	developmental	diseases.19,20 SOX11 plays a crucial 
role	in	neurodevelopment	and	organogenesis.	Sox11	expression	de-
creases along neurodevelopment progression and is absent in most 
normal	 adult	 tissues	 expect	 some	 niches	 locating	 stem	 cells	 with	
proliferation and differentiation potential.21	 A	 number	 of	 in	 vitro	
and	 in	vivo	experiments	have	substantiated	the	role	of	Sox11	as	a	








rupted function in patients with schizophrenia.23
In	 the	 present	 study,	 we	 aimed	 to	 examine	 the	 association	 of	
the human SOX11 gene with susceptibility for schizophrenia in an 
independent	Chinese	Han	case-control	sample	set	and	explore	the	
potential for the polymorphisms of this gene as schizophrenia diag-
nosis	biomarkers.
2  | METHODS AND MATERIAL S
2.1 | Subjects





confirmed	 by	 at	 least	 two	 experienced	 psychiatrists	 according	 to	
the	Diagnostic	 and	Statistical	Manual	 of	Mental	Disorders,	 fourth	




from the current study. The healthy controls included in the current 
study had no history of mental illness or any other neurological or 
medical condition that are suspected to be associated with schizo-






means that most of the nucleotides in the gene region are nominated 
as	the	flanking	sequences.	The	SNPs	were	selected	by	downloading	
the	 information	of	all	 the	SNPs	within	and	neighboring	the	human	
SOX11	 gene	 from	 the	 International	 HapMap	 project	 database	 on	




cially	 available	QIAamp	DNA	Blood	Mini	Kit	 (QIAGEN).	 The	SNPs	
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were	genotyped	by	either	polymerase	chain	reaction	(PCR)	restric-
tion	 fragment	 length	polymorphism	 (RFLP)	 analysis	or	direct	DNA	
sequencing.	All	primers	were	designed	by	software	Oligo	6.0	(MBI	
Inc).	PCR	products	were	either	completely	digested	with	4	U	restric-










according to the manufacturer's instructions.
2.5 | Luciferase assay
Human	 SH-SY5Y	 neuroblastoma	 cells	 with	 endogenous	 Sox11 
expression	were	 seeded	 in	 24-well	 plates	 and	 transiently	 trans-
fected	 with	 equimolar	 amounts	 of	 various	 pGL3-promoter	 vec-
tors	 (Promega)	containing	different	 inserted	SNP-site(s)	by	using	
LipofectamineTM	 2000	 (Invitrogen).	 pRLCMV	 (Promega)	 was	 co-
transfected as an internal control of transfection efficiency. The 
transfected	 cells	 were	 harvested	 after	 48	 hours.	 Luminescence	
was	 measured	 by	 the	 dual-luciferase	 reporter	 assay	 system	
(Promega)	 using	 a	 Centro	 LB960	 96-well	 luminometer	 (Berthold	
Technologies).
2.6 | Electrophoretic mobility shift assay (EMSA)
Nuclear	 extracts	were	prepared	 as	previous	described.24	Biotin-
labeled and corresponding unlabeled oligonucleotides containing 
the	various	genotypes	were	synthesized	by	BGI	Genomics.	Equal	
amounts of complementary oligonucleotides were heated at 95°C 








Distribution of gender and the difference of age between cases 
and	 controls	 were	 evaluated	 by	 Pearson's	 chi-squared	 test	 and	
Student's	 t	 test.	 Statistical	 differences	 in	 genotypic	 and	 allelic	
distribution between patients and controls were evaluated by 
the	Pearson's	 chi-squared	 test	 at	 a	 significance	 level	 of	 0.05.	 To	
analyze the association between SOX11	 SNP	 genotypic	 distribu-
tion	and	schizophrenia,	multiple	logistic	regression	analyses	were	
TA B L E  1  List	of	SNPs	included	in	the	present	study
rs code Marker order Positiona 
Distance from 
SNP1 (kb) Allele Change HCBb  MAF
Sample set 
HWE P Case HWE P Control HWE P
rs1821797 SNP1 5671640 0 C>T 0.227 .160 .457 .233
rs4485539 SNP2 5724305 52.7 T>C 0.322 .348 .147 .966
rs7563508 SNP3 5727884 56.2 G>A 0.389 .268 .259 .665
rs4547512 SNP4 5739199 67.6 T>G 0.100 .390 .757 .403
rs4371338 SNP5 5755481 82.8 A>G 0.478 .159 .383 .255
rs7596062 SNP6 5772751 101.1 T≥G 0.500 .517 .426 .793
rs16864067 SNP7 5777782 106.1 G>A 0.367 .921 .455 .715
rs12478711 SNP8 5785238 113.6 G>A 0.389 .982 .371 .524
rs2564045 SNP9 5787341 115.7 A>G 0.456 .715 .490 .352
rs2252087 SNP10 5793753 122.1 G>T 0.244 .443 .285 .803
rs2564055 SNP11 5803780 132.1 A>C 0.243 .331 .145 .845
rs1366733 SNP12 5807622 136.0 C>T 0.267 .626 .209 .771
rs11892518 SNP13 5818625 147.0 C>T 0.389 .672 .321 .820
rs10929818 SNP14 5834699 163.1 A>G 0.400 .571 .566 .807










and	 log-additive	 (major	 allele	 homozygotes	 vs.	 heterozygotes	 vs.	
minor	 allele	 homozygotes).	 In	 codominant	model,	 each	 genotype	
gives	a	different	and	non-additive	risk;	therefore,	we	compared	the	
major	allele	homozygotes	(the	most	frequent	alleles)	to	heterozy-





heterozygotes were compared with both allele homozygotes. In 
the	log-additive	model,	each	copy	of	allele	modified	the	risk	in	an	
additive	 form.	The	haplotype	 frequencies	were	estimated	by	 the	
expectation	 maximization	 algorithm.	 Pairwise	 linkage	 disequilib-
rium	(LD)	between	any	two	alleles	was	evaluated	by	D′	and	r2 val-
ues.	Odds	ratio	 (OR)	and	their	95%	confidence	 intervals	 (95%	CI)	





harva	rd.edu/~purce	ll/gpc/cc2.html).	 The	 sample	 had	 approxi-
mately	80%	power	to	detect	allele	frequency	differences	assuming	
an	OR	of	1.5	with	a	minor	allele	frequency	of	0.1.	The	Bonferroni	
correction for multiple testing was carried out to control inflation 
of the type I error rate. Results were considered significant at two 
tailed P < .05.
3  | RESULTS
3.1 | Single-allele association of selected SOX11 
SNPs with schizophrenia
None	of	the	genotype	distributions	of	the	15	selected	SNPs	in	case	




SNP9,	 rs2252087-SNP10,	 rs2564055-SNP11,	 rs1366733- 
SNP12,	 and	 rs11892518-SNP13)	 showed	 statistical	 differences	 in	
allele	frequencies	between	cases	and	controls	(Table	2).	After	rigor-
ous	Bonferroni	correction,	 four	SNPs	 located	 in	 the	SOX11	3′UTR	
remained significantly associated with schizophrenia in the allele 
frequencies;	SNP7	(allelic	P	=	.0022),	SNP8	(allelic	P	=	.0009),	SNP9	
(allelic	P	=	.0027),	and	SNP10	(allelic	P	=	.0025)	(Table	2).	
3.2 | Genotypic association of nine SNPs located 
in the SOX11 3′UTR
To	further	investigate	the	nine	SNPs	significantly	associated	with	
schizophrenia	after	single-allele	analysis,	we	examined	the	geno-
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TA B L E  2  Genotype	and	allele	frequencies	of	15	SNPs	in	the	human	SOX11 gene between schizophrenia patients and controls
No. subjects Allele and frequencya  χ2 P(Pb ) OR (95% CI)
  C T   
SNP1 Case 1209	(0.787) 327	(0.213) χ2 = 0.9745 0.93	(0.79-1.08)
Control 2150	(0.800) 538	(0.200) p = .3236
  C T   
SNP2 Case 520	(0.339) 1016	(0.661) χ2 = 4.7643 0.86	(0.76-0.99)
Control 1003	(0.372) 1693	(0.628) p = .0291
  A G   
SNP3 Case 614	(0.400) 922	(0.600) χ2	=	3.3068 0.89	(0.78-1.01)
Control 1155	(0.428) 1541	(0.572) p = .0691
  G T   
SNP4 Case 163	(0.106) 1373	(0.894) χ2 = 0.2670 0.95	(0.77-1.16)
Control 300	(0.111) 2396	(0.889) p = .6053
  A G   
SNP5 Case 780	(0.508) 756	(0.492) χ2	=	1.8788 1.092	(0.96-1.24)
Control 1310	(0.486) 1386	(0.514) p = .1705
  G T   
SNP6 Case 783	(0.510) 753	(0.490) χ2 = 6.9301 1.18	(1.04-1.34)
Control 1260	(0.468) 1434	(0.532) p	=	.0085
  A G   
SNP7 Case 620	(0.404) 914	(0.596) χ2 = 9.3616 1.22	(1.07-1.39)
Control 962	(0.357) 1734	(0.643) p	=	.0022	(.033)
  A G   
SNP8 Case 640	(0.417) 896	(0.583) χ2 = 11.0119 1.24	(1.09-1.41)
Control 982	(0.365) 1708	(0.635) p	=	.0009	(.0135)
  A G   
SNP9 Case 857	(0.558) 679	(0.442) χ2	=	9.0128 1.21	(1.07-1.38)
Control 1374	(0.510) 1320	(0.490) p	=	.0027	(.0405)
  G T   
SNP10 Case 1117	(0.727) 419	(0.273) χ2 = 9.1470 1.23	(1.08-1.42)
Control 1841	(0.683) 855	(0.317) p	=	.0025	(.00375)
  A C   
SNP11 Case 1111	(0.723) 425	(0.277) χ2	=	7.5864 1.21	(1.06-1.39)
Control 1841	(0.683) 855	(0.317) p = .0059
  C T   
SNP12 Case 1117	(0.727) 419	(0.273) χ2 = 6.1519 1.19	(1.04-1.37)
Control 1863	(0.691) 833	(0.309) p = .0132
  C T   
SNP13 Case 911	(0.595) 621	(0.405) χ2	=	4.1815 0.87	(0.77-0.99)
Control 1689	(0.626) 1007	(0.374) p = .0409
  A G   
SNP14 Case 869	(0.566) 667	(0.434) χ2 = 1.2700 1.08	(0.95-1.22)
Control 1477	(0.548) 1219	(0.452) p	=	.2598
  C T   
SNP15 Case 1119	(0.729) 417	(0.271) χ2 = 0.4919 1.05	(0.91-1.21)
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and	 log-additive	 (P	 =	 .0279);	 (b)	 SNP6,	 codominant	 (P	 =	 .0426),	
recessive	 (P	 =	 .0126),	 and	 log-additive	 (P	 =	 .0260);	 (c)	 SNP7,	 co-
dominant	 (P	 =	 .0218),	 dominant	 (P	 =	 .0047),	 and	 overdominant	
(P	=	0374);	(d)	SNP8,	codominant	(P	=	.0092),	dominant	(P	=	.0017),	
recessive	 (P	=	 .0310),	and	 log-additive	 (P	=	 .0279);	 (e)	SNP	9,	co-
dominant	(P	=	.0331),	dominant	(P	=	.0283),	recessive	(P	=	.0065),	




additive	 (P	 =	 .0210);	 and	 (i)	 SNP13,	 codominant	 (P	 =	 .0260)	 and	
dominant	(P	=	.0189)	(Table	3).
3.3 | Haplotype analysis of selected SOX11 SNPs 
with schizophrenia
To	analyze	 the	haplotype	 structure,	 the	pairwise	LD	 (linkage	dis-
equilibrium)	 of	 the	 15	 SNPs	 in	 our	 sample	 set	was	 computed	 by	
the	standardized	measure	D′	value.	D′	value	of	two	SNPs	ranging	
between	0.8	and	1.0	 indicated	 strong	LD.	Four	 strong	LD	haplo-
types	were	 constructed.	 The	 LD	haplotype	 structure	was	 shown	
in	Figure	1.	To	investigate	whether	any	haplotype	would	result	 in	
a	higher	 risk	 for	 schizophrenia,	 all	 specific	 and	global	 haplotypes	
of	 the	15	SNPs	were	tested.	Specific	P-values	 for	 individual	hap-
lotype	combinations,	global	P-values	for	each	haplotype	and	esti-
mated	haplotype	frequencies	in	cases	and	controls	are	summarized	
in Table 4. The global association analyses revealed positive results 
for	the	second	haplotype	(χ2	=	11.941,	P	=	.0076)	and	third	haplo-
type	 (χ2	 =	9.729,	P	 =	 .0078).	All	 the	 four	haplotypes	had	 specific	
haplotype	 combinations	 associated	 with	 schizophrenia.	 For	 the	




P	 =	 .0015).	 For	 the	 third	 haplotype,	 two	 haplotype	 combina-
tions	 were	 associated	 with	 schizophrenia;	 A-G-A-C	 (χ2	 =	 8.502,	
P	=	.0036)	and	G-T-C-T	(χ2	=	7.921,	P	=	.0049).	For	the	last	haplo-
type,	 the	 T-A-C	 haplotype	 combination	 showed	 association	with	
schizophrenia	(χ2	=	4.418,	P	=	.0356).
3.4 | Luciferase assay for the schizophrenia-
associated SNPs
Considering	 the	 distal	 3′	 location	 of	 positively	 associated	 SNPs,	
they may modulate SOX11	gene	expression.	Therefore,	several	lucif-
erase	reporter	vectors	were	constructed	by	cloning	DNA	fragments	
of	200-250	bps	 spanning	each	candidate	SNPs	 into	 the	3′	 side	of	
the	 luciferase	 open	 reading	 frame	 (ORF)	 in	 the	 pGL3.0-promoter	
reporter.	 The	 SNP-site	 was	 in	 close	 proximity	 to	 the	 midpoint	 of	
the	 cloned	 sequence.	 The	 insert	was	 sequenced,	 and	 a	 single	 site	
mutation	 was	 performed	 with	 the	 QuikChange	 II	 Site-Directed	
Mutagenesis	Kit	(Agilent	Technologies)	to	attain	the	allele	of	oppo-
site	 risk.	 rs7596062-SNP6,	 rs16864067-SNP7,	 rs12478711-SNP8,	
rs2564045-SNP9,	 rs2252087-SNP10,	 and	 rs2564055-SNP11	
were all positively associated with schizophrenia and scattered in 
the	 second	 or	 third	 haplotypes,	 which	were	 the	 two	 significantly	
schizophrenia-associated	 haplotypes	 globally.	 The	 reporter	 gene	
expression	assays	were	performed	using	the	Human	neuroblastoma	
SH-SY5Y	cell	 line.	The	cloning	site	was	to	the	3′	side	of	 luciferase	
gene,	 following	 SV40	 polyA	 signaling	 sequence,	 which	 partially	
mimicked	 the	 SNPs	 genome	 environment.	 As	 shown	 in	 Figure	 2,	
in	SH-SY5Y	cells,	4	out	of	the	6	SNP	pairs	exhibited	transcriptional	
regulatory effect on luciferase reporter gene compared with the 
empty	control,	which	could	be	classified	into	3	groups	according	to	
TA B L E  4  Estimated	haplotype	frequencies	and	case-control	haplotype	results	of	the	human	SOX11 gene
Combinations Haplotype
Haplotype frequencya 
χ2 P OR (95%CI)
global
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the	 regulatory	 tendency	of	non-risk	alleles:	 (a)	upregulation,	SNP6	
(~1.27-fold)	 and	SNP10	 (~2.15-fold),	while	 risk	 alleles	exhibited	no	
activation	or	a	weak	inhibitory	effect;	(b)	no	effect,	SNP8,	and	SNP9;	
and	(c)	downregulation,	SNP7	(~93%)	and	SNP11	(~78%),	while	the	
risk	 alleles	 exhibited	 stronger	 inhibitory	 effect,	 52%	 and	 45%,	 re-
spectively. These results indicated that SOX11	 3′	distal	 SNPs	may	
modulate	its	expression.
3.5 | Electrophoretic Mobility Shift Assay (EMSA) 
for the Schizophrenia-associated SNPs
According	to	these	results,	 these	SNP	alleles	may	work	as	anchor	
points	of	regulatory	DNA	motifs,	and	the	risk/non-risk	alleles	have	





identify	 the	 corresponding	 TFs,	 the	 DNA	 sequences	 were	 sub-
jected	to	MatInspector	(www.genom	atix.de/)	for	in-silico	analysis.	
We	found	that	a	single	nucleotide	substitution	caused	remarkable	




to	 hindbrain	 (mRNA-seq	 data	 from	 Allen	 brain	 institute,	 http://
www.brain	-map.org/).	The	remaining	14	unambiguously	expressed	




opment,	 PLAG1,	 and	 (d)	 regional	 specific,	 POU4F1,	 and	DMRT3.	
Among	all	these	transcription	factors,	we	found	that	over-expres-
sion	of	ZNF239	inhibited	reporter	gene	expression,	which	is	more	
effective	on	 rs16864067-SNP7	 risk	 allele;	while,	 on	 the	 contrary,	
ZNF239	knockdown	released	the	inhibitory	effect	which	was	more	
effective	 on	 rs16864067-SNP7	 non-risk	 allele	 (Figure	 4A).	 EMSA	
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rs2564055
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performed	with	eukaryotic	or	prokaryotic	over-expressed	ZNF239	
protein	showed	higher	affinity	to	risk	allele	probe	(Figure	4B).	These	
results indicated that SOX11	 3′	 distal	 SNPs	may	modulate	 its	 ex-
pression	by	serving	as	cis-regulatory	elements	and	recruiting	tran-
scriptional activators or repressors.
4  | DISCUSSION
In	 the	 present	 research,	 we	 applied	 an	 association	 study	 for	 the	
human SOX11 gene to investigate the involvement of this gene with 
schizophrenia	 in	an	 independent	case-control	sample	set	 including	
768	 schizophrenia	 patients	 and	 1348	 healthy	 controls.	 Allelic	 fre-
quencies	of	9	out	of	15	selected	SNPs	covering	 the	whole	SOX11 
gene region showed differences between cases and controls. 
After	 strict	 Bonferroni	 correction,	 4	 SNPs	 (rs16864067-SNP7,	
rs12478711-SNP8,	rs2564045-SNP9,	and	rs2252087-SNP10)	were	
still significantly associated with schizophrenia. The genotypic as-
sociation	of	the	9	SNPs	under	different	models	by	multiple	logistic	
regression	analyses	showed	that	these	SNPs	were	associated	with	
schizophrenia significantly under at least two different genetic mod-
els.	 Two	 LD	 blocks	 containing	 the	 4	 Bonferroni-significant	 SNPs	
also	 showed	 global	 differences	 in	 frequency	 between	 cases	 and	
controls. These data suggested SOX11 as a susceptibility gene for 
schizophrenia.
However,	it	is	worth	noting	that,	in	the	light	of	the	construction	
of	 schizophrenia	polygenic	 inheritance	model,	 the	most	 important	
and	challenging	task	 is	to	 interpret	the	numerous	potential	schizo-
phrenia	genetic	susceptibility	 loci.	Therefore,	 in	the	present	study,	
other than investigating the association between the SOX11 gene 
and	schizophrenia,	we	also	dissected	the	effect	of	the	risk/non-risk	
alleles	 on	 the	 expression	 of	 the	 SOX11 gene. These schizophre-
nia-associated	SNPs	are	in	the	distal	3′	UTR	of	SOX11 with potential 
transcriptional	 function.	We	examined	whether	 the	allelic	variants	
of	associated	SNPs	may	modulate	SOX11	gene	expression	by	in	vitro	
luciferase reporter assay and electrophoretic mobility shift assay 





quences	 containing	 these	 SNPs	 to	 recruit	 TFs,	 and	 EMSA	 results	
showed	a	single	nucleotide	substitution	caused	remarkable	changes	
in	TF	prediction	among	all	examined	SNP	pairs	of	DNA	sequences,	




had	 more	 effective	 reaction	 with	 risk	 allele	 of	 rs16864067-SNP7	
other	than	the	non-risk	allele.	The	interaction	of	ZNF239	with	3′UTR	
region of SOX11 gene may inhibit its transcriptional level; there-
fore,	high	affinity	of	 risk	allele	of	 rs16864067-SNP7	with	ZNF239	




response to environmental alterations by conditionally regulating 
SOX11	expression	level.
The	expression	level	of	Sox11	is	spontaneously	upregulated	in	
neurogenesis region with an indispensable role in neuronal regen-
eration	and	neuroplasticity.	It	has	been	reported	that	Sox11	expres-
sion increased immediately and significantly after electroconvulsive 
shock	 (ECS),	 an	 effective	 treatment	 for	 patients	 suffering	 from	
schizophrenia and major depression disorders.27	 Also,	 Sox11	 and	
its	putative	binding	partner	Brn1	were	induced	in	CA1	and/or	DG	
of hippocampus following transient forebrain ischemia in rat.28 
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textual	specific	manner.29 It is notable that other than the role in 
early-stage	neurodevelopment,	abnormal	expression	of	Sox11	may	
lead to clinical symptoms due to adaptability decline of schizophre-
nia	 for	 adverse	 stimulus	 in	external	 environment.	However,	more	
than one thousand schizophrenia candidate genes have been re-
ported with poor repeatability and verification by thousands of 
candidate	gene	and	genome-wide	association	studies	since	1965.30 
Thus,	elaborate	and	convinced	 interpretation	of	SOX11 in schizo-
phrenia	 emergence	 is	 required	 and	 critical	 for	 approval	 of	 its	 in-
volvement in schizophrenia etiology by further functional studies 
of SOX11 in mice.
In	 conclusion,	 our	 independent	 case-control	 association	 study	
confirmed a significant association between potential functional 
polymorphisms of the human SOX11	gene	located	in	its	distal	3′UTR	
and	schizophrenia,	indicating	that	SOX11 may contribute to schizo-
phrenia	risk,	and	SOX11 polymorphisms and haplotypes in the distal 
3′UTR	of	the	gene	might	modulate	the	SOX11 transcriptional activity 
by	serving	as	cis-regulatory	elements	and	recruiting	transcriptional	
activators or repressors. The functional polymorphisms may serve 
as the diagnostic targets for schizophrenia.
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